Improving care for patients with advanced lung cancer using personalized approaches
Optimizing Supportive Care for Patients with Metastatic Lung Cancer in the Era of Precision Oncology
This study is looking to improve support for people with metastatic lung cancer who have certain genetic mutations by testing a new way to help them feel more comfortable and make better decisions about their care, based on what they and their doctors think is important.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10910885 on NIH RePORTER |
What this research studies
This research focuses on enhancing supportive care for patients with metastatic lung cancer, particularly those with specific genetic mutations. It aims to develop and test a new palliative care intervention that addresses the unique needs of these patients, helping them manage uncertainty about their prognosis and make informed decisions about their care. The study will involve refining the intervention based on feedback from patients and healthcare providers, followed by a pilot test to evaluate its feasibility and acceptability compared to standard care. Ultimately, the goal is to improve patients' quality of life and their ability to discuss their preferences for care.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with metastatic lung cancer who have targetable oncogenic driver mutations.
Not a fit: Patients with early-stage lung cancer or those without specific genetic mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life and decision-making processes for patients with metastatic lung cancer.
How similar studies have performed: Previous research has shown promising results in improving supportive care for cancer patients through tailored interventions, suggesting this approach may be effective.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Petrillo, Laura Anne — Massachusetts General Hospital
- Study coordinator: Petrillo, Laura Anne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.